Benzinga | Sep 30, 2021 04:53AM EDT

Stifel Initiates Coverage On Zentalis Pharmaceuticals with Buy Rating, Announces Price Target of $84

Stifel analyst Bradley Canino initiates coverage on Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Buy rating and announces Price Target of $84.